-
Mashup Score: 0Maternal and neonatal benefits of induction of labor - 12 month(s) ago
In a recent study, induction of labor was found safe and beneficial in pregnant women at 39 weeks of gestation, with increased risks only seen for shoulder dystocia in nulliparous women.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet
-
Mashup Score: 0The COVID-19 public health emergency is over. Should health care workers keep wearing face masks with patients? - 12 month(s) ago
Physicians debate merits of face covers as virus becomes endemic in the population.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
“The risk reduction [from #masking] was around 10% to 18%, which may be important on a population level, especially when considering cumulative effects over time." #COVID19 https://t.co/WIDVgGJbxp
-
-
Mashup Score: 0Haywood Brown, MD, on the current landscape of maternal mortality in the United States - 12 month(s) ago
At the 2023 ACOG Annual Clinical and Scientific Meeting, Haywood Brown, MD, discusses the current maternal mortality rate in the United States, as well as disparities affecting different racial and ethnic groups.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
At the 2023 ACOG Annual Clinical and Scientific Meeting, Haywood Brown, MD, discusses the current #maternalmortality rate in the United States, as well as disparities affecting different racial and ethnic groups. #ACOG2023 https://t.co/iQKLlozdbN
-
-
Mashup Score: 0The importance of primary HPV screening - 12 month(s) ago
Anne Banfield, MD, discusses the highlights from her presentation on primary HPV screening at the 2023 ACOG Annual Clinical and Scientific Meeting in Baltimore, Maryland.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
Anne Banfield, MD, discusses the highlights from her presentation on primary #HPV screening at the 2023 ACOG Annual Clinical and Scientific Meeting in Baltimore, Maryland. #ACOG2023 https://t.co/qQc8qYEfH0
-
-
Mashup Score: 1Substance use in women’s health - 12 month(s) ago
At the 2023 ACOG Annual Clinical & Scientific Meeting, details on substance use disorder were provided, including methods of treatment and the screening process for women.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
There are multiple biopsychosocial factors impacting #substanceuse disorder, making it more than a “moral failure” or “choice.” Learn more about how substance use impacts #womenshealth https://t.co/I83sXVmzx5
-
-
Mashup Score: 0'It's about time,' fezolinetant approval and latest research showcased at annual meeting - 12 month(s) ago
Genevieve Neal-Perry, MD, PhD, talks about the recent approval of fezolinetant (Veozah; Astellas Pharma) and her latest phase 3 research presented at the 2023 ACOG Annual Clinical and Scientific Meeting.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
"It's about time, right?" Fezolinetant approved for treating #hotflashes. #menopause #ACOG2023 https://t.co/xt8tFewKmo
-
-
Mashup Score: 2Using hormone therapies for menopause - 12 month(s) ago
At the 2023 ACOG Annual Clinical & Scientific Meeting, Gloria Richard-Davis MD, MBA, NCMP, FACOG, discussed the importance of using hormone therapies to treat menopause symptoms.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
At the 2023 ACOG Annual Clinical & Scientific Meeting, Gloria Richard-Davis MD, MBA, NCMP, FACOG, discussed the importance of using #hormonetherapy to treat #menopause symptoms. #ACOG2023 https://t.co/2RrLLsxdaE
-
-
Mashup Score: 0FDA approves fezolinetant for vasomotor symptoms - 12 month(s) ago
Fezolinetant (Veozah; Astellas Pharma) is now the first neurokinin 3 receptor antagonist approved for the treatment of vasomotor symptoms associated with menopause.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
ICYMI: Fezolinetant (Veozah; Astellas Pharma) is now the first neurokinin 3 receptor antagonist approved for the treatment of vasomotor symptoms associated with #menopause. #FDA #Approval FDA Approval: https://t.co/2WWynvU99C
-
-
Mashup Score: 1Accuracy of the Deep Pelvic Endometriosis Index - 1 year(s) ago
In a recent study, the Deep Pelvic Endometriosis Index accurately predicted operating and hospital stay length, along with postoperative complications, in patients with deep pelvic endometriosis.
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
Accurate predictions were found for operating time, hospital stay, and #postoperative complications using the Deep Pelvic #Endometriosis Index (dPEI) score. This may help clinicians prepare patients for #surgery. https://t.co/6fm6HixfCO
-
-
Mashup Score: 1Erica Gunderson, PhD, discusses link between lactation and maternal cardiometabolic health - 1 year(s) ago
Erica Gunderson, PhD, MS, MPH, RD, senior research scientist, Kaiser Permanente Northern California Division of Research, and professor of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine discusses what it means to be the recipient of the 2022-2023 March of Dimes Agnes Higgins Award, and her lifetime research linking breastfeeding and future maternal cardiometabolic…
Source: Contemporary OB/GYNCategories: Latest Headlines, OBGYNTweet-
Erica Gunderson, PhD, MS, MPH, RD, discusses what it means to be the recipient of the 2022-2023 March of Dimes Agnes Higgins Award, and her lifetime research linking #breastfeeding and future maternal #cardiometabolic health. https://t.co/gpk2Fnhjy9
-
Following #inductionoflabor, #maternal and #neonatal outcomes saw reduced risks at 39 weeks. However, an increased risk of shoulder dystocia was found in #nulliparous women. https://t.co/IbLOsnMU5R